About CannPal

Innovative and naturally derived therapeutic products for pets

CannPal Animal Therapeutics is a global leader in the development of innovative, cannabinoid-derived therapeutic products to provide veterinarians and pet owners with clinically validated and standardised therapeutics to treat animals in a safe and more natural way.

Presently, the Company is developing products containing CBD, THC and other active ingredients for registration and commercialisation as veterinary medicines and nutraceuticals in the areas of pain, inflammation, mood and dermatological skin conditions.

CannPal is a subsidiary of AusCann Group Holdings (ASX:AC8) an Australian, Publicly listed company focused on the development and commercialisation of cannabinoid-derived therapeutic products to address unmet needs for humans and animals within Australia and internationally. You can learn more about AusCann Group Holdings here


To provide veterinarians and pet owners with innovative and naturally derived therapeutics to treat pets in a safe and ethical way


To be a global leader in the development of therapeutic products for companion animals using plant compounds that influence the endocannabinoid system

The Problem:

The animal population is ageing and age-related disease is growing at a quicker rate than new product innovation and development.

It is estimated that over 60% of dogs between the ages of 7 and 11 years will experience arthritis; 1 in 2 will develop some form of cancer. 1 in 4 dogs will die from the disease. 61% of felines over the age of 6 have arthritis in at least 1 joint and 30% will be affected by a tumour at some point in their lives.

However, innovation in the animal health industry is lacking. The current medications available to pets for these indications have been shown to include side effects such as nausea, loss of appetite, depression and internal bleeding. Old human drugs are being repurposed for animal use to try and fill the gaps, but there is still a lack of naturally derived therapies specific to pets, to treat animals in a safer and ethical way.


Since the emergence of medical cannabis, researchers have discovered the endocannabinoid system as one of the most important physiological functions in the mammalian body. It is a system of receptors and compounds that are involved in almost every disease state, especially inflammation, pain and neurological conditions.

CannPal is working to further explore the natural healing abilities of compounds that can target the endocannabinoid system, to develop novel and efficacious therapies for your companions, without the associated negative side effects, to enhance their quality of life.